The COMET Trial: Clinical Results in Moderate to Severe RA

First Page		Document Content
Date: 2014-06-09 11:19:20 Psoriasis Immunology Monoclonal antibodies Amgen Etanercept TNF inhibitor Pharmaceutical drug Calcipotriol Wyeth Medicine Pharmacology Immunosuppressants		The COMET Trial: Clinical Results in Moderate to Severe RA Add to Reading List Source URL: www.dermatology.ca Download Document from Source Website File Size: 223,45 KB Share Document on Facebook

	Agentes biológicos en psoriasis Actualización en terapéutica Agentes biológicos en psoriasis Dr. Julio Magliano DocID: 1uXAh - View Document
	Official Launch Confirmed - MGC Derma’s CBD Herbal Cream for Relief of Psoriasis Symptoms 4 JanuaryFor personal use only DocID: 1uXqR - View Document
	Psoriasis 2016_Scientific Program.indd DocID: 1uemj - View Document
	SOCIÉTÉ SUISSE DU PSORIASIS ET DU VITILIGO OPTIONS THÉRAPEUTIQUES POUR LE TRAITEMENT DU psoriasis DocID: 1sBn1 - View Document
	SCHWEIZERISCHE PSORIASIS UND VITILIGO GESELLSCHAFT KURZÜBERSICHT ZUR Psoriasis Psoriasis Arthritis DocID: 1rJas - View Document